Form Type: 4

SEC EDGAR Link
Acccession Number:0000899243-20-012859
Date:2020-05-10
Issuer: AIMMUNE THERAPEUTICS, INC. (AIMT)
Original Submission Date:

Reporting Person:

BJERKHOLT ERIC
AIMMUNE THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 300 BRISBANE, CA 94005-1884

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.0001 PAR VALUE 2020-05-10 A 2,420 a $0.00 45,387 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares represent restricted stock units ("rsus") and will be settled in common stock upon vesting. the rsus vest as to 100% of the underlying shares on september 11, 2020 (the "vesting date"), subject to the reporting person's continued service relationship with the issuer on the vesting date.
f2 includes 9,375 rsus and will be settled in common stock upon vesting. the rsus vest in three successive, equal, annual installments measured from march 1, 2020, subject to the reporting person's continued service relationship with the issuer on each such vesting date
f3 includes 9,843 rsus and will be settled in common stock upon vesting. the rsus vest in four successive, equal, annual installments measured from march 1, 2019, subject to the reporting person's continued service relationship with the issuer on each such vesting date.
f4 includes 7,031 rsus and will be settled in common stock upon vesting. the rsus vest in four successive, equal, annual installments measured from march 1, 2018, subject to the reporting person's continued service relationship with the issuer on each such vesting date.

Elevate your investments